Literature DB >> 16448543

Recent insights into the signals that control alphabeta/gammadelta-lineage fate.

Jens Peter H Lauritsen1, Mariëlle C Haks, Juliette M Lefebvre, Dietmar J Kappes, David L Wiest.   

Abstract

During thymopoiesis, two major types of mature T cells are generated that can be distinguished by the clonotypic subunits contained within their T-cell receptor (TCR) complexes: alphabeta T cells and gammadelta T cells. Although there is no consensus as to the exact developmental stage where alphabeta and gammadelta T-cell lineages diverge, gammadelta T cells and precursors to the alphabeta T-cell lineage (bearing the pre-TCR) are thought to be derived from a common CD4- CD8- double-negative precursor. The role of the TCR in alphabeta/gammadelta lineage commitment has been controversial, in particular whether different TCR isotypes intrinsically favor adoption of the corresponding lineage. Recent evidence supports a signal strength model of lineage commitment, whereby stronger signals promote gammadelta development and weaker signals promote adoption of the alphabeta fate, irrespective of the TCR isotype from which the signals originate. Moreover, differences in the amplitude of activation of the extracellular signal-regulated kinase- mitogen-activated protein kinase-early growth response pathway appear to play a critical role. These findings will be placed in context of previous analyses in an effort to more precisely define the signals that control T-lineage fate during thymocyte development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16448543     DOI: 10.1111/j.0105-2896.2006.00349.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  14 in total

Review 1.  Determining γδ versus αß T cell development.

Authors:  Maria Ciofani; Juan Carlos Zúñiga-Pflücker
Journal:  Nat Rev Immunol       Date:  2010-08-20       Impact factor: 53.106

Review 2.  Towards a molecular understanding of the differential signals regulating alphabeta/gammadelta T lineage choice.

Authors:  Sang-Yun Lee; Jason Stadanlick; Dietmar J Kappes; David L Wiest
Journal:  Semin Immunol       Date:  2010-05-14       Impact factor: 11.130

Review 3.  The thymus chapter in the life of gut-specific intra epithelial lymphocytes.

Authors:  Hilde Cheroutre; Florence Lambolez
Journal:  Curr Opin Immunol       Date:  2008-05-02       Impact factor: 7.486

Review 4.  Expanding roles for ThPOK in thymic development.

Authors:  Dietmar J Kappes
Journal:  Immunol Rev       Date:  2010-11       Impact factor: 12.988

5.  Lineage divergence at the first TCR-dependent checkpoint: preferential γδ and impaired αβ T cell development in nonobese diabetic mice.

Authors:  Ni Feng; Patricia Vegh; Ellen V Rothenberg; Mary A Yui
Journal:  J Immunol       Date:  2010-12-10       Impact factor: 5.422

6.  TCR-mediated ThPOK induction promotes development of mature (CD24-) gammadelta thymocytes.

Authors:  Kyewon Park; Xi He; Hyung-Ok Lee; Xiang Hua; Yi Li; David Wiest; Dietmar J Kappes
Journal:  EMBO J       Date:  2010-06-15       Impact factor: 11.598

Review 7.  The Tec kinases Itk and Rlk regulate conventional versus innate T-cell development.

Authors:  Amanda L Prince; Catherine C Yin; Megan E Enos; Martin Felices; Leslie J Berg
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

Review 8.  The root of many evils: indolent large granular lymphocyte leukaemia and associated disorders.

Authors:  Ranran Zhang; Mithun Vinod Shah; Thomas P Loughran
Journal:  Hematol Oncol       Date:  2010-09       Impact factor: 5.271

9.  Characteristics of IL-17 induction by Schistosoma japonicum infection in C57BL/6 mouse liver.

Authors:  Dianhui Chen; Xueping Luo; Hongyan Xie; Zhiyan Gao; Huilong Fang; Jun Huang
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

10.  Primary cutaneous B-cell lymphoma with abundant reactive gamma/delta T-cells within the skin lesion and peripheral blood.

Authors:  Mitsuaki Ishida; Muneo Iwai; Keiko Yoshida; Akiko Kagotani; Hidetoshi Okabe
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.